KLK3 and prostate cancer: The overall PPV of PSA concentration higher than 3·0 ng/mL (ie, number of prostate cancers identified divided by number of PSA readings of more than 3·0 ng/mL) at detecting prostate cancer was 32·1% (18 of 56; 95% CI 20·3–46·0).